Riskpilot← Back to searchSign inGet full accessKadhem Medical AB
ABActiveOrg 5592973134Manhemsvägen 8General medical practice activities · NACE 8621Est. 20212 employees
Revenue 2025
SEK 1,2M
-6% vs 2024
EBITDA margin
8.5%
+47% vs 2024
Equity ratio
67.9%
Financial strength
Net profit 2025
SEK 84K
+46% vs 2024
| Revenue | SEK 1,2M | -6% |
| EBITDA | SEK 104K | +47% |
| Net profit | SEK 84K | +46% |
| Total assets | SEK 669K | +8% |
| Equity | SEK 454K | +23% |
| Employees | 2 | — |
Legal name
Kadhem Medical AB
Org number
5592973134
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 januari 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Uthyrning av läkartjänster inom sluten- och primärvård. Utbildning, föreläsning och medicinsk rådgivning. Handel med finansiella instrument och därmed förenlig verksamhet.
Address
Manhemsvägen 8
Email
alaa.kadhem@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | −0 | 1 209 | 1 306 | 1 230 |
| Staff expenses | — | −0 | −631 | −1 055 | −743 |
| EBITDA | — | −11 | 482 | 71 | 104 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 0 | −11 | 482 | 71 | 104 |
| Net financials | — | 0 | 1 | 1 | 2 |
| Profit before tax | 0 | −11 | 373 | 73 | 106 |
| Tax | −0 | — | −75 | −15 | −22 |
| Net profit | 0 | −11 | 298 | 57 | 84 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 25 | 41 | 618 | 617 | 669 |
| Equity | 25 | 14 | 313 | 370 | 454 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | 27 | 195 | 136 | 105 |
| Total debt | — | 27 | 195 | 136 | 105 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20212025
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20212025
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20212025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ZK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AK Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kadhem Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zohra Kadhem | Deputy Chief Executive Officer | 0 companies |
| Alaa Kadhem | Chief Executive Officer | 0 companies |